Cargando…
Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis – clinical and academic value
Given the high prevalence and the enormous impact on key outcomes, comorbidities are important to consider, especially in patients with RA. Comorbidity indices are tools to quantify the impact of the overall burden of coexisting diseases on a specific outcome of interest. Until now, no gold standard...
Autor principal: | Radner, Helga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650270/ https://www.ncbi.nlm.nih.gov/pubmed/37871917 http://dx.doi.org/10.1093/rheumatology/kead436 |
Ejemplares similares
-
Viewpoint: Could better understanding of risk factors for comorbidities pave the way towards personalized therapy in rheumatoid arthritis?
por: Majnik, Judit, et al.
Publicado: (2023) -
Autoantibodies in normals – the value of predicting rheumatoid arthritis
por: Dörner, Thomas, et al.
Publicado: (2004) -
Viewpoint: Assessing the value of mental health treatments in Europe
por: Simon, Judit, et al.
Publicado: (2023) -
The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint
por: Kardas, Przemyslaw, et al.
Publicado: (2020) -
Measuring Health-Related Quality of Life With Multimodal Data: Viewpoint
por: Clay, Ieuan, et al.
Publicado: (2022)